Four initial public offerings (IPO) -- Windlas Biotech, Exxaro Tiles, Krsnaa Diagnostics and Devyani International -- have opened for subscription from Wednesday.
Nuvoco Vistas Corporation, part of the Nirma Group, on Wednesday said it has fixed a price band of Rs 560-570 a share for its Rs 5,000 crore initial public offering
Market regulator observes several shortcomings in the existing procedure
Nykaa, her brainchild, has grown into India's top e-commerce site for beauty products.
Promoters and investors selling shares via OFS upto 43.1 million
Edible oil major Adani Wilmar Ltd (AWL) on Monday filed the draft red herring prospectus with markets regulator Sebi for an initial public offer to raise up to Rs 4,500 crore.
Of this, Rs 3,750 crore will be fresh issue portion and OFS of Rs 2,267.5 crore
Riding on huge investor interest in the healthcare sector, five pharma companies are tapping the initial public offering (IPO) market over the next couple of weeks to raise over Rs 8,000 crore.
Sources said the market regulator is yet to give a go-ahead to the exchange
The IPO will mainly consist of new shares, and more bankers may be added as plans progress
Ravi Kant Jaipuria-promoted Devyani International prices its IPO between Rs 86-90
The deal could be announced in the coming weeks and would be a prelude to an initial public offering (IPO) by Oyo, the source said
Rolex Rings subscribed 9.3 times a day before close
Low interest rates, hefty returns have driven record demand for IPOs, but with valuations for newly public companies now at levels last seen during dot-com bubble, some analysts are raising concerns
The three-day initial public offer (IPO) will open on August 4 and conclude on August 6
Rolex Rings subscribed 3.5 times on Day-1, Tatva Chintan to list on Thursday
The Sebi chief said the regulator is examining the minimum shareholding and public float at a concept level.
Bikhchandani wrote Zomato's first cheque of Rs 4.7 crore in 2010 and was its only investor in the first four funding rounds.
SPACs or blank cheque companies are formed to raise capital in an initial public offering (IPO) with the purpose of using the proceeds to identify and merge with a target company.
The wholly-owned subsidiary of Glenmark Pharma is issuing Rs 1,060 cr fresh equity and offer for sale of 6.3 million shares worth Rs 453.6 crore